PROTHENA CORPORATION PUBLIC LIMITED COMPANY Shares Outstanding (Cover Page)
PROTHENA CORPORATION PUBLIC LIMITED COMPANY (PRTA) had Shares Outstanding (Cover Page) of 51.34 million shares as of 2026-07-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-30: Entity Common Stock, Shares Outstanding 51.34M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 52.35M shares.
- 2026-02-20: Entity Common Stock, Shares Outstanding 53.83M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 53.83M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 51.34M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 52.35M shares 10-Q · filed 2026-05-07 |
| 2026-02-20 | 53.83M shares 10-K · filed 2026-02-27 |
| 2025-10-31 | 53.83M shares 10-Q · filed 2025-11-06 |
| 2025-07-25 | 53.83M shares 10-Q · filed 2025-08-04 |
| 2025-05-01 | 53.83M shares 10-Q · filed 2025-05-08 |
| 2025-02-20 | 53.83M shares 10-K · filed 2025-02-27 |
| 2024-11-06 | 53.81M shares 10-Q · filed 2024-11-12 |
| 2024-08-01 | 53.78M shares 10-Q · filed 2024-08-08 |
| 2024-05-01 | 53.77M shares 10-Q · filed 2024-05-08 |
| 2024-02-15 | 53.72M shares 10-K · filed 2024-02-22 |
| 2023-10-26 | 53.67M shares 10-Q · filed 2023-11-02 |
| 2023-07-28 | 53.54M shares 10-Q · filed 2023-08-03 |
| 2023-04-28 | 52.75M shares 10-Q · filed 2023-05-04 |
| 2023-02-17 | 52.56M shares 10-K · filed 2023-02-28 |
| 2022-10-26 | 48.38M shares 10-Q · filed 2022-11-03 |
| 2022-07-29 | 46.92M shares 10-Q · filed 2022-08-08 |
| 2022-04-28 | 46.81M shares 10-Q · filed 2022-05-05 |
| 2022-02-18 | 46.69M shares 10-K · filed 2022-02-25 |
| 2021-10-28 | 46.59M shares 10-Q · filed 2021-11-04 |
| 2021-07-29 | 45.05M shares 10-Q · filed 2021-08-05 |
| 2021-05-04 | 44.18M shares 10-Q · filed 2021-05-11 |
| 2021-02-18 | 39.99M shares 10-K · filed 2021-02-26 |
| 2020-10-30 | 39.92M shares 10-Q · filed 2020-11-04 |
| 2020-07-31 | 39.91M shares 10-Q · filed 2020-08-06 |
| 2020-05-01 | 39.91M shares 10-Q · filed 2020-05-06 |
| 2020-02-21 | 39.91M shares 10-K · filed 2020-03-03 |
| 2019-10-25 | 39.90M shares 10-Q · filed 2019-11-05 |
| 2019-07-19 | 39.90M shares 10-Q · filed 2019-08-06 |
| 2019-04-30 | 39.86M shares 10-Q · filed 2019-05-07 |
| 2019-02-08 | 39.86M shares 10-K · filed 2019-03-15 |
| 2018-10-26 | 39.86M shares 10-Q · filed 2018-11-06 |
| 2018-07-20 | 39.84M shares 10-Q · filed 2018-08-07 |
| 2018-04-20 | 39.82M shares 10-Q · filed 2018-05-09 |
| 2018-02-09 | 38.54M shares 10-K · filed 2018-02-26 |
| 2017-10-20 | 38.45M shares 10-Q · filed 2017-11-07 |
| 2017-07-21 | 38.28M shares 10-Q · filed 2017-08-09 |
| 2017-04-21 | 38.02M shares 10-Q · filed 2017-05-09 |
| 2017-02-10 | 35.03M shares 10-K · filed 2017-02-27 |
| 2016-10-21 | 34.49M shares 10-Q · filed 2016-11-02 |
| 2016-07-22 | 34.40M shares 10-Q · filed 2016-08-02 |
| 2016-04-22 | 34.35M shares 10-Q · filed 2016-05-04 |
| 2016-02-12 | 34.34M shares 10-K · filed 2016-02-25 |
| 2015-10-23 | 31.52M shares 10-Q · filed 2015-11-02 |
| 2015-07-24 | 31.38M shares 10-Q · filed 2015-08-05 |
| 2015-04-24 | 31.29M shares 10-Q · filed 2015-05-06 |
| 2015-02-27 | 27.40M shares 10-K · filed 2015-03-13 |
| 2014-10-24 | 27.38M shares 10-Q · filed 2014-11-04 |
| 2014-07-25 | 27.38M shares 10-Q · filed 2014-08-05 |
| 2014-04-25 | 21.90M shares 10-Q · filed 2014-05-05 |
| 2014-03-03 | 21.90M shares 10-K · filed 2014-03-07 |
| 2013-10-31 | 21.86M shares 10-Q · filed 2013-11-12 |
| 2013-07-31 | 17.68M shares 10-Q · filed 2013-08-13 |
| 2013-04-30 | 17.68M shares 10-Q · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |